Safety Study of Anti-Asthma Agent BMEC-1217B
NCT00425971
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
BMEC-1217B
Sponsor
Medigreen Biotechnology Corp.